The anti-apoptotic role of Ginkgolide B via mitochondrial permeability transition pore inhibition in retinal ischemia-reperfusion
Biochemical and Biophysical Research Communications · 2024-04 · 705 · 149722
DOI: 10.1016/j.bbrc.2024.149722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-04. Verfasst von Xiou Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. Hauptthemen laut MEDLINE: Mitochondrial Permeability Transition Pore, Glaucoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Research and Development, Xi’an Jiaotong University, Natural Science Basic Research Program of Shaanxi Province.
Abstract (Originalsprache)
This research delves into the effectiveness of Ginkgolide B (GB), a compound from Ginkgo biloba, in combating cell death caused by glaucoma, with a focus on mitochondrial impairment and the mitochondrial permeability transition pore (mPTP). Utilizing models of high intraocular pressure and in vitro glaucoma simulations, the study investigates GB's impact on retinal progenitor cells (RPCs) under oxygen-glucose deprivation/reperfusion (OGD/R) and in a rat glaucoma model. The study methodologies included apoptosis assessment, apoptotic marker analysis via Western blot, and mitochondrial structure and function evaluation. The findings reveal that GB notably decreases apoptosis in RPCs exposed to OGD/R in vitro, and reduces ischemia-reperfusion damage in vivo. GB's protective role is attributed to its ability to preserve mitochondrial integrity, maintain membrane potential, regulate calcium levels, and inhibit mPTP opening. These results underscore GB's potential as a therapeutic agent for acute primary angle-closure glaucoma, highlighting its capability to alleviate mitochondrial damage and apoptosis in RPCs and retinal nerve fiber layer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
- Department of Ophthalmology, The First Affiliated Hospital of Northwest University, Xi'an No. 1 Hospital, Xi'an, Shaanxi, 710002, China.
- Institute of Neurobiology, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China.
- Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. Electronic address: kangqy@xjtu.edu.cn.
Förderung
- Research and Development
- Xi’an Jiaotong University
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Wang, X., Hu, B., Zhang, H., Zhou, S., Wu, W., Tan, Z., Sun, M., & Kang, Q. (2024). The anti-apoptotic role of Ginkgolide B via mitochondrial permeability transition pore inhibition in retinal ischemia-reperfusion. Biochemical and Biophysical Research Communications, 705, 149722. https://doi.org/10.1016/j.bbrc.2024.149722
Vancouver
Wang X, Hu B, Zhang H, Zhou S, Wu W, Tan Z, et al. The anti-apoptotic role of Ginkgolide B via mitochondrial permeability transition pore inhibition in retinal ischemia-reperfusion. Biochemical and Biophysical Research Communications. 2024;705:149722. doi:10.1016/j.bbrc.2024.149722
BibTeX
@article{Wang2024,
author = {Wang, Xiou and Hu, Baoqi and Zhang, Hanyue and Zhou, Sijia and Wu, Wenfei and Tan, Zizhu and Sun, Meiqi and Kang, Qianyan},
title = {The anti-apoptotic role of Ginkgolide B via mitochondrial permeability transition pore inhibition in retinal ischemia-reperfusion},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {705},
pages = {149722},
doi = {10.1016/j.bbrc.2024.149722}
}
EUVIMED